You just read:

FDA Grants IND Approval for Phase IIa Clinical Trial Using Stemedica's itMSC Therapy to Treat Alzheimer's Disease

News provided by

Stemedica Cell Technologies, Inc.

Jun 09, 2015, 09:13 ET